Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Google, Netflix & A24 Are Betting Big on AI: Should Hollywood Be Worried?
Corbin Bolies of Variety explains how AI is reshaping Hollywood, from Google's A24 partnership to Netflix's major investment in AI filmmaking.
Meet the AI Robot That's Taking Over the Most Dangerous Job in Restaurants
Miso Robotics CEO Rich Hull discusses Flippy Fry Station, the future of AI-powered restaurant automation and how acquiring Zume's IP could reshape food robotics
The AI Boom's Next Reckoning: Wall Street Wants Profits, Not Promises
After two years of AI-fueled spending, Wall Street is asking what's next. Gil Luria breaks down monetization, valuations, winners, losers, and AI's future.
Meet the AI Designed for Mental Health, Not Just Conversation
Talkspace CEO Dr. Jon Cohen joins us to explain TEE, the rise of AI for emotional support, and the future of digital mental health care.
Oil Traders on Edge: Is This Ceasefire Real or Just a Pause Before the Next Shock?
James Bikales, Energy Reporter at POLITICO, breaks down the Middle East agreement, oil market risks, the Strait of Hormuz, and what's next.
The Bionic Hand Teaching Robots to Think Like Humans
PSYONIC CEO Dr. Aadeel Akhtar explains how the company's Ability Hand restores sensation for amputees while helping train smarter, more capable AI robots.
